Screener
Rhythm Pharmaceuticals, Inc. RYTM Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Total current assets | 430,090 | 466,916 |
| Property and equipment, net | 1,065 | 1,104 |
| Right-of-use asset | 2,936 | 3,049 |
| Intangible assets, net | 5,106 | 5,319 |
| Restricted cash | 601 | 522 |
| Other long-term assets | 2,518 | 3,286 |
| Total assets | $442,316 | $480,196 |
| Liabilities, Convertible Preferred Stock and Stockholders’ equity |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s intangibles (net)?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported intangibles (net) of $5.11M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s intangibles (net) changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s intangibles (net) decreased by 14.3% year-over-year, from $5.96M to $5.11M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s intangibles (net)?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s intangibles (net) has grown at a 3.4% compound annual growth rate (CAGR), from $4.66M to $5.32M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude